Dr. Aracely Acevedo: The BCKDK inhibitor BT2 is a chemical uncoupler that lowers mitochondrial ROS productions and de nova lipogenesis
At our 2024 GCI Postdoctoral Showcase, Postdoctoral Fellow Aracely Acevedo presented a poster about the BCKDK inhibitor being a chemical uncoupler. To learn more about her research, reach out to Dr. Acevedo at aracevedo@chapman.edu. ABSTRACT: The objective of this study, conducted at UCLA, was to investigate alternative molecular mechanisms by which BT2 may confer cardioprotection